The potential of factor XII inhibitors in preventing hereditary angioedema attacks
Sign Up to like & getrecommendations! Published in 2025 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2025.2512128
Abstract: ABSTRACT Introduction Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of subcutaneous and/or submucosal swelling (angioedema). Current HAE-specific medications primarily focus on either inhibiting plasma bradykinin or kallikrein, or replacing C1-esterase… read more here.
Keywords: factor xii; hereditary angioedema; fxii inhibition; potential factor ... See more keywords